Liver Cancer
Copyright ©The Author(s) 2004.
World J Gastroenterol. May 15, 2004; 10(10): 1397-1401
Published online May 15, 2004. doi: 10.3748/wjg.v10.i10.1397
Table 1 The clinical information of the 34 HCC patients with tumor thrombosis in bile duct
ItemsCases (%)
Sex
Male28 (82.4%)
Female6
HBV infection
HBsAg+34 (100%)
Liver cirrhosis32 (94.1%)
AFP
> 20 μg/L30 (88.2%)
≤ 20 μg/L4
Obstructive jaundice
+12 (12, 35.3%)
-
Ueda classification
Type I2
Type II8
Type IIIa16
Type IIIb1
Type IV7
Treatment
Surgical resection31 (91.2%)
Removal of BDT + HAL + HAI2
Only removal of BDT1
Survival
> 1 yr20 (20/28, 71.4%)
> 3 yr3
> 15 yr1
HCC recurrence
Within 1 yr14 (14/28, 50.0%)
Within 3 mo9 (9/31, 29.0%)